Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
International Journal of Medicinal Mushrooms
Fator do impacto: 1.423 FI de cinco anos: 1.525 SJR: 0.431 SNIP: 0.661 CiteScore™: 1.38

ISSN Imprimir: 1521-9437
ISSN On-line: 1940-4344

Volumes:
Volume 21, 2019 Volume 20, 2018 Volume 19, 2017 Volume 18, 2016 Volume 17, 2015 Volume 16, 2014 Volume 15, 2013 Volume 14, 2012 Volume 13, 2011 Volume 12, 2010 Volume 11, 2009 Volume 10, 2008 Volume 9, 2007 Volume 8, 2006 Volume 7, 2005 Volume 6, 2004 Volume 5, 2003 Volume 4, 2002 Volume 3, 2001 Volume 2, 2000 Volume 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.v1.i1.20
pages 9-29

The Extraction and Development of Antitumor-Active Polysaccharides from Medicinal Mushrooms in Japan (Review)

Takashi Mizuno
Department of Applied Biological Chemistry, Faculty of Agriculture, Shizuoka University, 4-13-9 Seinan-Cho, Fujieda-Shi 426-0063, Japan

RESUMO

It has been known for many years that most mushrooms with known effects against cancer belong to the family Polyporaceae s.l. (Agaricales s.l.). However, the components responsible for such action have not been clearly defined. In Japan, in 1968, a hot water extract from some edible mushrooms belonging to the family Polyporaceae s.l., showed a marked host-mediated antitumor activity. Since then, numerous researchers have isolated active polysaccharides and have identified them to be (1→3)-β-D-glucopyranans with a (1→6)-β-D-glucosyl branch containing protein. Several antitumor polysaccharides, some hetero-β-glucans and their protein complexes, such as xyloglucans and acidic β-glucan containing uronic acid, are insoluble in water. They were, however, isolated from the extracts using large amounts of dilute alkali with Japanese (8 species) and Chinese (5 species) mushrooms. Several trials have been made to enhance activity by chemical modification, such as polyalcohols formed by a mild Smith degradation and the products formed by BH4-reduction after 104-oxidation. Mushroom polysaccharides are considered to be biological response modifiers (BRM), or immunopotentiators, because of their action mechanism. In Japan, three different polysaccharide antitumor agents have been developed from the fruit body, mycelium, and cultured medium, of three mushroom species.


Articles with similar content:

Therapeutic Effects of Substances Occurring in Higher Basidiomycetes Mushrooms: A Modern Perspective
Critical Reviews™ in Immunology, Vol.19, 1999, issue 1
Solomon P. Wasser, Alexander L. Weis
Beneficial Effects of Edible and Medicinal Mushrooms on Health Care
International Journal of Medicinal Mushrooms, Vol.3, 2001, issue 4
Tetsuro Ikekawa
Medicinal Properties of Substances Occurring in Higher Basidiomycetes Mushrooms: Current Perspectives (Review)
International Journal of Medicinal Mushrooms, Vol.1, 1999, issue 1
Solomon P. Wasser, Alexander L. Weis
Contents and Antioxidant Activities of Polysaccharides in 14 Wild Mushroom Species from the Forest of Northeastern China
International Journal of Medicinal Mushrooms, Vol.17, 2015, issue 12
Guiqiang Wang, Jian-Yong Wu, Lijian Xu, Qinggui Wang
Antitumor and Hypoglycemic Activities of Polysaccharides from the Sclerotia and Mycelia of Inonotus obliquus (Pers.: Fr.) Pil. (Aphyllophoromycetideae)
International Journal of Medicinal Mushrooms, Vol.1, 1999, issue 4
Cun Zhuang, Kuniaki Abe, Tadashi Kiho, Takashi Mizuno, Hidehumi Okamoto, Sophie Leclerc, Shigeo Ukai, Laurent Meijer